Table 1 Socio-demographic and clinical features of the 30 patients with HCC
Patients baseline characteristics | |
|---|---|
Socio-demographical features | |
Sex-ratio (M:F) | 2.75 |
Median age, yr (IQRa) | 53.7 (43–64) |
Low socio-economical standardb n (%) | 5 (16.7) |
Living in Abidjan n (%) | 18 (60.0) |
Ethnical origin | |
Akan-speaking areas n (%) | 11 (36.6) |
Gur-speaking areas n (%) | 5 16.6) |
Kru-speaking areas n (%) | 4 (13.3) |
Mandé-speaking areas n (%) | 7 (23.3) |
Foreign born (Burkina Faso) n (%) | 3 (10.0) |
Lifestyle features | |
History of heavy drinking n (%) | 7 (23.3) |
Tobacco use n (%) | 3 (10.0) |
Cassava consumption n (%) | 19 (63.3) |
Maize flour consumption n (%) | 16 (53.3) |
Peanut consumption n (%) | 20 (66.7) |
Risk factors of infection | |
Dental treatment n (%) | 8 (26.6) |
Invasive medical practicesc n (%) | 11 (36.6) |
Ritual scarifications n (%) | 12 (40.0) |
Sex-transmitted infections n (%) | 3 (10.0) |
Clinical features | |
Metabolic disease (Type 2 diabetes, obesity) n (%) | 6 (20.0) |
Hepatomegaly n (%) | 25 (83.3) |
Jaundice n (%) | 21 (70.0) |
Bruises n (%) | 7 (23.3) |
Portal anastomoses n (%) | 5 (16.6) |
Liver pain n (%) | 20 (66.7) |
Ascites n (%) | 21 (70.0) |
Multi-nodular tumors n (%) | 27 (90.0) |
ECOG clinical stage**** n (%) | |
- 1 or 2 | 8 (26.7) |
- 3 or 4 | 22 (73.3) |
Biochemistry | |
Alpha-feotoprotein >400 ng/mL n (%) | 13 (43.3) |
Hemoglobin (g/dL ± SD) | 10.2 ± 2.0 |
Prothrombin ratio (% ± SD) | 69.3 ± 20.5 |
ASAT (UI/mL, mean ± SEM) | 211 ± 45 |
ALAT (UI/mL, mean ± SEM) | 143 ± 26 |